Effect of combined treatment with recombinant interleukin-2 and allicin on pancreatic cancer

Author： Wang Cong-Jun   Wang Chao   Han Jiang   Wang Yong-Kun   Tang Lin   Shen Dong-Wei   Zhao Yi   Xu Rong-Hua   Zhang Hui  

Publisher： Springer Publishing Company

ISSN： 0301-4851

Source： Molecular Biology Reports, Vol.40, Iss.12, 2013-12, pp. : 6579-6585

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recombinant fusion toxins for cancer treatment

By Kreitman Robert J  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 8, 2002-12 ,pp. : 785-791

Informa Healthcare

Access to resources Recommend Favorite

Expression and Production of Recombinant Human Interleukin-2 in Potato Plants

By Park Y.   Cheong H.  

Protein Expression and Purification, Vol. 25, Iss. 1, 2002-06 ,pp. : 160-165

Academic Press

Access to resources Recommend Favorite

Covalent Association of Protein Disulfide Isomerase with Recombinant Human Interleukin 2 in Vitro

By Ye J.M.   Key C.J.   Wolfe J.L.  

Biochemical and Biophysical Research Communications, Vol. 223, Iss. 1, 1996-06 ,pp. : 153-159

Elsevier

Access to resources Recommend Favorite

Cetuximab: still an option in the treatment of pancreatic cancer?

By Faloppi Luca   Andrikou Kalliopi   Cascinu Stefano  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 5, 2013-05 ,pp. : 791-801

Informa Healthcare

Access to resources Recommend Favorite

Further characterization of the binding of human recombinant interleukin 2 to heparin and identification of putative binding sites

By Najjam S.  

Glycobiology, Vol. 8, Iss. 5, 1998-05 ,pp. : 509-516

Oxford University Press

Access to resources Recommend Favorite